In most animals, mitochondrial DNA is inherited from the mother, but it is unclear exactly how paternal mitochondria are excluded. Vincent Galy and colleagues now report that in the nematode Caenorhabditis elegans, the oocyte destroys sperm mitochondria through autophagy. Their findings hint that a similar mechanism may also operate in mammals.
In most animals, mitochondrial DNA is inherited from the mother, but it is unclear exactly how paternal mitochondria are excluded. Vincent Galy and colleagues now report that in the nematode Caenorhabditis elegans, the oocyte destroys sperm mitochondria through autophagy. Their findings hint that a similar mechanism may also operate in mammals.
C. elegans sperm contain unique membranous organelles that associate with mitochondria. The researchers observed that shortly after fertilization, these organelles and their associated mitochondria become surrounded by autophagosomes, as detected by fluorescence imaging of two proteins involved in autophagosome formation (LGG-1 and LGG-2). Moreover, after fertilization, the membranous organelles become decorated with ubiquitin molecules associated with autophagy (K63-linked ubiquitin chains; Fig. 1 ), although the mitochondria are not similarly tagged.
The findings suggest that autophagy destroys sperm mitochondria through a process that involves recognition of membranous organelles associated with the mitochondria. In support of this model, the researchers found that sperm mitochondria persist in oocytes depleted of various proteins involved in autophagy (Fig. 2 ).
In mammals, nearly 100 paternal mitochondria enter the egg during fertilization. Cellular elements of the sperm become ubiquitinated and mitochondria are degraded by an unknown mechanism. Galy and colleagues found that after fertilization, the mid-piece of mouse sperm, which contains mitochondria, lit up with fluorescent dye-tagged antibodies that recognize several proteins involved in autophagy. This observation hints that mammalian sperm may also be degraded by autophagy, a process known to be essential for embryo survival past the eight-cell stage. Two homeobox genes operate in the mouse embryo to support the differentiation of female germ cells and prompt them to enter meiosis, according to a new study.
During formation of the germline in the embryo, female germ cells initiate meiosis and male germ cells enter a quiescent phase. Very little is known about the regulators that prompt meiosis in the female germ line, although Stra8 (stimulated by retinoic acid 8) is one of a few genes known be a positive regulator.
Gabriel Livera and colleagues examined the role of two homeobox genes implicated in the development of many organs, Msx1 and Msx2 (muscle segment homeobox-like, also known as Hox-7 and Hox-8). They found that both are strongly expressed in the fetal ovary during the time meiosis is initiated. Most of the germ cells in the ovaries of mice deficient in both Msx1 and Msx2 did not initiate meiosis and instead underwent apoptosis, indicating a role for these factors in the initiation of meiosis. Ovaries in these mice also showed defects in Stra8 expression, which was initiated but did not persist. This suggests that Msx1 and Msx2 may be responsible for maintaining or increasing Stra8 expression, rather than initiating it. In support of the idea that Msx1 regulates Stra8, MSX1 was found to bind to Stra8 regulatory sequences and activate its transcription in cell culture.
The researchers next examined Msx1 and Msx2 expression in cells and cultured ovaries in response to retinoic acid and the bone morphogenic proteins BMP2 and BMP4, which are known to be present in the ovary during fetal life. Their findings suggest that these factors up-regulate Msx1 and Msx2.
MSX1 and MSX2 are also highly expressed in the human fetal ovary during the initiation of meiosis, suggesting that these genes may have a conserved role in the ovary. How MSX1 and MSX2 operate with DMRT1 (doublesex and mab-3 related transcription factor), another element shown to up-regulate STRA8, is one of the many questions that remain to be answered. Researchers have uncovered how stem cells that give rise to sperm breach cell barriers as they migrate to their proper location in the testis after transplantation: They deploy the small GTPase Rac1, which has previously been implicated in the homing of hematopoietic stem cells to their niche in the bone marrow.
Spermatogonial stem cells can be transplanted into infertile testes in mice and give rise to sperm. But these stem cells must first make an arduous journey from their starting point, the interior of the semiferous tubules, to their final destination abutting the basement membrane of these tubules, where the stem cell niche is thought to reside. The stem cells must pass through the tight junctions of Sertoli cells that line the tubules and foster spermatogenesis. These junctions are so impermeable that they are often referred to as the blood-testis barrier.
Previous studies suggested that b1-integrin helps mediate attachment of spermatogonial stem cells to the basement membrane, but it has been unclear which other molecules are involved in targeting these cells.
Seiji Takashima et al. took a look at the RAC proteins, which are known to operate in conjunction with integrins. They found that RAC1 was expressed in spermatogonial stem cells and that cells lacking RAC1 activity did not home to the niche. It seems that RAC1 prompts the expression of the cell membrane protein claudin 1 (CLDN) on spermatogonial stem cells, enabling the cells to bind to claudin proteins on Sertoli cells and allowing them to ratchet through the cell junctions.
These studies using an artificial system of spermatagonial stem cell transplantation are of biological importance because the homing ability is acquired early in development and may play a role in the establishment of the spermatogonial stem cells and the regulation of stem cell niches.
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Homeobox genes ready the uterus for implantation, according to a study in mice that hints at ways to affect fertility without the use of hormones.
Msx1 and Msx2, members of the muscle segment homeobox gene family, participate in numerous developmental processes; for instance, they have recently been implicated in promoting meiosis of female germ cells in the embryo. Previous studies by S.K. Dey and colleagues had shown that Msx1 is expressed in the mouse uterus at high levels for only one day, corresponding to the time of uterine receptivity to implantation, which occurs 4 days after fertilization. In the new study, the researchers further explored the function of these genes in implantation. The researchers generated mice with uteri deficient in Msx1 or both Msx1 and Msx2. The mice lacking Msx1 had multiple defects. For instance, implantation did not occur in a proper crypt or ''nidus,'' and these mice had impaired fertility. Mice deficient in both Msx genes in the uterus were completely infertile.
These two genes seem to mediate morphological changes in uterine luminal epithelial cells that prepare these cells for implantation. Normally these cells transit from a columnar to a cuboidal conformation prior to blastocyst attachment on Day 4, a process that loosens cell-cell adhesions and prepares the uterus for attachment of the blastocyst. Uteri lacking Msx1 and Msx2 do not undergo this change in uterine cell morphology and remain highly polarized and columnar. During implantation, these cells also show increased expression of E-cadherin, an important protein for cell-cell adhesion.
Further studies suggested that Msx1 and Msx2 regulate levels of Wnt5a, which in turn affects formation of the E-cadherin-b-catenin complex at adherens junctions. Application of Wnt5a to cultured uterine epithelial cells was found to compromise blastocyst outgrowth.
Dey and colleagues propose that the hormonal changes that prepare the uterus for implantation prompt the expression of Msx1 the day before implantation. Their results suggest a feedback loop between Msx1 and estrogen-induced LIF (leukemia inhibitory factor), a cytokine essential for implantation that may down-regulate Msx1.
The findings have potential clinical implications, particularly given that previous microarray studies suggest that MSX1 and MSX2 expression levels are altered in women during the window of implantation. Strategies that temporarily increase uterine levels of MSX1/MSX2 may extend the window of implantation for in vitro fertilization, the researchers suggest. Since MSX genes convey and maintain uterine receptivity without altering ovarian hormone levels or uterine sensitivity to these hormones, further exploration of how MSX1 and MSX2 operate may also aid in the development of nonhormonal contraceptives. 
